Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.10.3.1 (
tyrosinase
)
9,065
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
(6R)5,6,7,8-tetrahydrobiopterin (6-BH4) directly regulates
tyrosinase
activity by specifically binding to a putative 13 amino acid domain. This domain has sequence homology to 6-BH4 binding sites already identified on phenylalanine hydroxylase and
4a-carbinolamine dehydratase
. Furthermore, this binding sequence appears to have been conserved during the evolution of
tyrosinase
as it has also been identified in the frog, mouse and human enzymes. 6-BH4 controls
tyrosinase
activity by an uncompetitive mechanism requiring the presence of L-tyrosine for effective down-regulation. When L-dopa is substrate, 6-BH4 does not inhibit the enzyme implicating separate binding sites for L-dopa and L-tyrosine on
tyrosinase
. Dihydropterin and 6-biopterin, the oxidation products of 6-BH4, do not inhibit
tyrosinase
significantly, indicating that melanin biosynthesis is controlled by a 6-BH4/6-biopterin redox-switch mechanism which can be initiated by photo-oxidation of 6-BH4.
...
PMID:A specific tetrahydrobiopterin binding domain on tyrosinase controls melanogenesis. 782 65